Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Touchefeu · SciRah

Researcher profile · Semantic Scholar

Y. Touchefeu

Share profile

Y. Touchefeu — researcher profile on SciRah

h-index: 27
Works: 200
Citations: 2,993

Most-cited papers

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.
Thierry Andre, E. Élez, H. Lenz, Lars Henrik Jensen +25 more
2025The Lancet154 citations
Semantic Scholar
887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial
E. Baudin, T. Walter, A. Béron, D. Smith +16 more
2022Annals of Oncology49 citations Open access
Semantic Scholar
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial.
C. Coutzac, F. Bibeau, M. Ben Abdelghani, T. Aparicio +17 more
2022Digestive and Liver Disease31 citations Open access
Semantic Scholar
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
C. Gallois, E. Bergen, É. Auclin, S. Pernot +25 more
2024ESMO Open25 citations Open access
Semantic Scholar
Prognostic factors of Colorectal Cancer patients with Brain Metastases.
Pauline Roussille, M. Auvray, D. Vansteene, T. Lecomte +20 more
2021Radiotherapy and Oncology24 citations Open access
Semantic Scholar
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study
E. Gkika, A. Grosu, Teresa Macarulla Mercade, Antonio Cubillo Gracián +5 more
2022Cancers23 citations Open access
Semantic Scholar
Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area
N. Chapelle, M. Péron, L. Quénéhervé, A. Bourget +6 more
2020Clinical and Translational Gastroenterology23 citations Open access
Semantic Scholar
Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study
P. Nizet, Y. Touchefeu, Solange Pécout, E. Cauchin +4 more
2021Supportive Care in Cancer22 citations Open access
Semantic Scholar
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors
P. Girot, E. Baudin, H. Sénellart, N. Bouarioua +14 more
2021Neuroendocrinology19 citations Open access
Semantic Scholar
Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis
N. Benzerdjeb, P. Dartigues, V. Képénékian, S. Valmary-Degano +91 more
2021Virchows Archiv18 citations
Semantic Scholar
Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in vitro and Preclinical Imaging Studies
Caroline Dagallier, F. Avry, Y. Touchefeu, Frédéric Buron +3 more
2021Frontiers in Medicine17 citations Open access
Semantic Scholar
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial
C. Féray, L. Campion, P. Mathurin, Isabelle Archambreaud +21 more
2023JHEP Reports14 citations Open access
Semantic Scholar
Postoperative hepatic arterial chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: A multicenter randomized phase II trial (PRODIGE 43 - PACHA-01).
M. Gelli, J. Ewald, M. Tanguy, G. Passot +16 more
2023Journal of Clinical Oncology10 citations
Semantic Scholar
15P STELLAR-001: A phase I study of the anti-C5aR avdoralimab in combination with the anti-PD-L1 durvalumab in advanced solid tumors
J. Bennouna, Y. Touchefeu, F. Ghiringhelli, N. Isambert +13 more
2022Annals of Oncology10 citations Open access
Semantic Scholar
Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study.
Iona Campo-Le-Brun, E. Grapinet, V. Aurillac, A. Hollebecque +21 more
2025European Journal of Cancer9 citations
Semantic Scholar
The experience of being a caregiver of patients with digestive cancer, from patients and caregivers’ perception: A mixed study
Charlotte Grivel, P. Nizet, Manon Martin, Solange Pécout +5 more
2023PLoS ONE9 citations Open access
Semantic Scholar
Prospective Multicentric Assessment of 68Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET
A. Lugat, E. Frampas, Y. Touchefeu, E. Mirallié +13 more
2023Cancers9 citations Open access
Semantic Scholar
Systematic upper endoscopy concomitant with colonoscopy performed within the colorectal cancer screening program: Impact on the patients' management.
O. Planade, B. Dessomme, N. Chapelle, M. Verdier +7 more
2021Clinics And Research in Hepatology and Gastroenterology9 citations Open access
Semantic Scholar
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study.
Jeannie M’Baloula, D. Tougeron, A. Boilève, E. Jeanbert +19 more
2024European Journal of Cancer8 citations Open access
Semantic Scholar
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study
A. Trécourt, Naoual Bakrin, O. Glehen, W. Gertych +109 more
2024Annals of Surgical Oncology8 citations Open access
Semantic Scholar
Clinical Management of Gastric Cancer Treatment Regimens.
Juliette Boilève, Y. Touchefeu, Tamara Matysiak-Budnik
2023Current Topics in Microbiology and Immunology8 citations
Semantic Scholar
Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis
M. Lelong, J. Raoul, Y. Touchefeu, Jean-marie Berthelot +3 more
2022Clinical Case Reports8 citations Open access
Semantic Scholar
Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patients
Boris Guiu, C. Bailly, Éric Vibert, G. Tlili +26 more
2026EClinicalMedicine7 citations Open access
Semantic Scholar
First results of nivolumab (NIVO) plus ipilimumab (IPI) vs NIVO monotherapy for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC) from CheckMate 8HW.
Thierry Andre, E. Élez, H. Lenz, Lars Henrik Jensen +16 more
2025Journal of Clinical Oncology7 citations
Semantic Scholar
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study
M. Auvray-Kuentz, V. Hautefeuille, L. de Mestier, C. Coutzac +15 more
2022International Journal of Cancer7 citations Open access
Semantic Scholar
Adhesion of Gastric Cancer Cells to the Enteric Nervous System: Comparison between the Intestinal Type and Diffuse Type of Gastric Cancer
P. Girot, N. Chapelle, L. Aymeric, A. Bessard +6 more
2022Cancers7 citations Open access
Semantic Scholar
KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicine
D. Coupez, P. Hulo, Y. Touchefeu, M. Denis +1 more
2021Expert Opinion on Biological Therapy7 citations
Semantic Scholar
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology
P. Galle, M. Kudo, J. Llovet, R. Finn +16 more
2021Liver international (Print)7 citations Open access
Semantic Scholar
Health-Related Quality of Life Analysis in Metastatic Colorectal Cancer Patients Treated by Second-Line Chemotherapy, Associated With Either Cetuximab or Bevacizumab: The PRODIGE 18 Randomized Phase II Study.
A. Bertaut, Y. Touchefeu, J. Blanc, O. Bouché +8 more
2021Clinical colorectal cancer7 citations
Semantic Scholar
Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients
J. Péron, Ismail Essâdi, P. Rousset, Laurent Villeneuve +101 more
2025Annals of Surgical Oncology6 citations
Semantic Scholar
Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) or NIVO monotherapy for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Expanded analyses from CheckMate 8HW.
H. Lenz, S. Lonardi, E. Élez, Lars Henrik Jensen +16 more
2025Journal of Clinical Oncology5 citations Open access
Semantic Scholar
541P Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Subgroup efficacy and expanded safety analyses from CheckMate 8HW
T. André, S. Lonardi, H. Lenz, L. Jensen +16 more
2024Annals of Oncology5 citations
Semantic Scholar
HEPANOVA: Final Efficacy and Safety Results from a Phase 2 Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant with Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
E. Gkikka, Y. Touchefeu, T. M. Mercade, A. C. Gracián +5 more
2022HPB5 citations Open access
Semantic Scholar
Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative 18F-FDG PET/CT: Don’t Forget the Thyroid!
A. Lugat, P. Hulo, C. Ansquer, Y. Touchefeu +3 more
2021Current Oncology5 citations Open access
Semantic Scholar
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trial.
P. Merle, Jean-Frédéric Blanc, K. Le Malicot, Jean-Marie Peron +15 more
2026The Lancet Gastroenterology and Hepatology4 citations
Semantic Scholar
[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.
E. Baudin, A. Durand, A. Béron, Denis Smith +27 more
2026The Lancet Oncology4 citations
Semantic Scholar
Combining Immune Checkpoint Inhibitors with Loco-Regional Treatments in Hepatocellular Carcinoma: Ready for Prime Time?
Juliette Boilève, V. Guimas, Arthur David, C. Bailly +1 more
2024Current Oncology4 citations Open access
Semantic Scholar
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer
V. Randrian, S. Pernot, B. Sionneau, Denis Smith +10 more
2022Frontiers in Medicine4 citations Open access
Semantic Scholar
O-16 HEPANOVA: Final efficacy and safety results from a phase 2 study of Tumor Treating Fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma
E. Gkika, A. Grosu, T. Macarulla, A. Cubillo +3 more
2021Annals of Oncology4 citations Open access
Semantic Scholar
Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas
Camille Goislard de Monsabert, Y. Touchefeu, B. Guiu, B. Campillo-Gimenez +13 more
2021Current Oncology4 citations Open access
Semantic Scholar
Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group.
C. Breton, A. Meyer, D. Malka, M. Matias +13 more
2021Clinics And Research in Hepatology and Gastroenterology4 citations Open access
Semantic Scholar
Predictive Factors of Chemotherapy Initiation after Biliary Drainage for Advanced Biliary Tract Cancer: A Retrospective Multicenter Study.
Miloud Azarfane, A. Lièvre, H. Sénellart, Beatrice Desomme +10 more
2021Journal of Gastrointestinal and Liver Diseases4 citations Open access
Semantic Scholar
48P (BREGO) Regorafenib combined with modified m-GEMOX in patients with advanced biliary tract cancer (BTC): A phase II randomized trial
E. Assenat, J. Blanc, M. Bouattour, L. Gauthier +7 more
2021Annals of Oncology4 citations Open access
Semantic Scholar
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.
M. Gelli, J. Ewald, M. Tanguy, G. Passot +17 more
2026Journal of Clinical Oncology3 citations
Semantic Scholar
IMbrave251: Final analysis of atezolizumab (atezo) + lenvatinib (lenva) or sorafenib (sora) vs lenva or sora alone in locally advanced or metastatic hepatocellular carcinoma (LA/mHCC) previously treated with atezo and bevacizumab (bev).
A. Vogel, I. Borbath, Shwetha Chiluveru, H. Chon +12 more
2026Journal of Clinical Oncology3 citations
Semantic Scholar
LBA29 Nivolumab plus ipilimumab vs nivolumab monotherapy for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): New results from CheckMate 8HW
S. Lonardi, H. Lenz, E. E. Fernandez, L. Jensen +16 more
2025Annals of Oncology3 citations
Semantic Scholar
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study.
R. Varnier, C. Toullec, S. Philonenko, A. Dupré +13 more
2024Digestive and Liver Disease3 citations Open access
Semantic Scholar
Preliminary safety data of the PRODIGE 81-FFCD 2101-TRIPLET-HCC trial assessing the triple combination atezolizumab-bevacizumab-ipilimumab in patients (pts) treated in systemic therapy for hepatocellular carcinoma (HCC).
P. Merle, Jean-Marie Peron, K. Le Malicot, M. Guarssifi +16 more
2024Journal of Clinical Oncology3 citations
Semantic Scholar
625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study
C. Gallois, M. E. Elez Fernandez, É. Auclin, E. Bergen +16 more
2023Annals of Oncology3 citations Open access
Semantic Scholar
Defibrotide for Sinusoidal Obstruction Syndrome and Nodular Regenerative Hyperplasia After Oxaliplatin-Based Hepatic Intra-Arterial Chemotherapy: A Case Report.
A. Druet, J. Mosnier, Erwan Corbineau, T. Matysiak-Budnik +2 more
2021Clinical colorectal cancer3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Tougeron×10
Invite
D. Tougeron — researcher profile on SciRah
T. Matysiak-Budnik×7
Invite
T. Matysiak-Budnik — researcher profile on SciRah
H. Sénellart×7
Invite
H. Sénellart — researcher profile on SciRah
S. Pernot×6
Invite
S. Pernot — researcher profile on SciRah

×5

Invite

E. Van Cutsem — researcher profile on SciRah

R. García-Carbonero×5

Invite

R. García-Carbonero — researcher profile on SciRah

Invite

M. L. Limon — researcher profile on SciRah

Invite

A. Lièvre — researcher profile on SciRah

Invite

J. Bennouna — researcher profile on SciRah

Invite

P. Girot — researcher profile on SciRah

C. de la Fouchardiére×4

Invite

C. de la Fouchardiére — researcher profile on SciRah

Invite

F. Aubin — researcher profile on SciRah